Evidence map›Paper›PMID 29730717›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2018

Long-term sequelae of sporadic cryptosporidiosis: a follow-up study.

Zsófia Iglói, L Mughini-Gras, L Nic Lochlainn, A Barrasa, J Sane, S Mooij, B Schimmer, J Roelfsema, W van Pelt, T Kortbeek

Open access · hybridAbstract read
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Frontiers in microbiology · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Health sequelae of human cryptosporidiosis-a 12-month prospective follow-up study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
  10. Article
  11. Tropical parasitology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Zsófia IglóiNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Zsofia.Igloi@rivm.nl.ORCID http://orcid.org/0000-0001-7537-6334
L Mughini-GrasNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
L Nic LochlainnNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
A BarrasaNational Centre for Epidemiology, Madrid, Spain.
J SaneNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
S MooijNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
B SchimmerNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
J RoelfsemaNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
W van PeltNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
T KortbeekNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
National Institute for Public Health and the Environment · NLCentro Nacional de Epidemiología · ESUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To determine the frequency of occurrence of sequelae following cryptosporidiosis. A follow-up study was performed during a case-control study for sporadic cryptosporidiosis in the Netherlands (2013-2016). Cryptosporidiosis cases were invited to complete a follow-up questionnaire 4 months after diagnosis. Using a case-crossover study design, we compared the frequencies of reported symptoms 4 months after the acute phase to those reported 4 months before the onset of illness and during illness. Frequencies of symptoms in the pre- to post-infection phases were also compared with those of a population control group. Cryptosporidium species-specific effects were also studied. Logistic regression was used to calculate adjusted odds ratios (aOR) for symptoms occurrence. Of the 731 available cases, 443 (60%) responded and 308 (42%) could be included in the follow-up study. The median age was 26 years (range 1-80); 58% were female; 30% were infected with C. hominis and 70% with C. parvum. Compared to before illness, cases were significantly more likely to report dizziness (OR = 2.25), headache (OR = 2.15), fatigue (OR = 2.04), weight loss (OR = 1.82), diarrhoea (OR = 1.50), abdominal pain (OR = 1.38) or joint pain (OR = 1.84). However, symptoms of joint pain and headache occurred among cases after illness at a rate that was not significantly different from that observed in the general population. There were no significant differences in post-infection symptom occurrence between C. hominis and C. parvum. The disease burden of cryptosporidiosis extends beyond the acute phase of the infection, with cases reporting both intestinal and extra-intestinal symptoms up to 4 months following infection.

Indexed as

Abdominal PainAdolescentAdultAgedAged, 80 and overArthralgiaCase-Control StudiesChildChild, PreschoolCryptosporidiosisCryptosporidiumDiarrheaDizzinessFatigueFemaleFollow-Up StudiesCase-crossover studyCryptosporidium hominisCryptosporidium parvumLong-term sequelaThe Netherlands

Identifiers

PMID29730717
PMCPMC6015106
OpenAlexW2799661396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.